Titlebook: Harmonic Maps Between Surfaces; (With a Special Chap Jürgen Jost Book 1984 Springer-Verlag Berlin Heidelberg 1984 Conformal Mappings.Harmon

二足動物

書目名稱Harmonic Maps Between Surfaces影響因子(影響力)




書目名稱Harmonic Maps Between Surfaces影響因子(影響力)學(xué)科排名




書目名稱Harmonic Maps Between Surfaces網(wǎng)絡(luò)公開度




書目名稱Harmonic Maps Between Surfaces網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Harmonic Maps Between Surfaces被引頻次




書目名稱Harmonic Maps Between Surfaces被引頻次學(xué)科排名




書目名稱Harmonic Maps Between Surfaces年度引用




書目名稱Harmonic Maps Between Surfaces年度引用學(xué)科排名




書目名稱Harmonic Maps Between Surfaces讀者反饋




書目名稱Harmonic Maps Between Surfaces讀者反饋學(xué)科排名

acclimate

發(fā)炎

Jürgen Josttically terrorise their neighbourhood with violence and aggression. Why was there this seeming contradiction between respectability and confrontation, and how widespread a phenomenon was this in the North?.

Jingoism

Jürgen Josttically terrorise their neighbourhood with violence and aggression. Why was there this seeming contradiction between respectability and confrontation, and how widespread a phenomenon was this in the North?.

障礙物

Jürgen Josttically terrorise their neighbourhood with violence and aggression. Why was there this seeming contradiction between respectability and confrontation, and how widespread a phenomenon was this in the North?.

有組織

PANG

一美元

Jürgen Josten über wirksame Pr?ventionsangebote und therapeutische Grundprinzipien bei der Behandlung. Die Autoren schildern, wie durch Einbeziehung des sozialen Umfeldes langfristig Erfolge bei der Pr?vention und Behandlung eines solchen Problemverhaltens erzielt werden k?nnen. Neu entwickelte, altersspezifis

fatty-acids

Jürgen JostD20 monoclonal antibody rituximab (R) to conventional chemotherapy has dramatically improved event-free survival (EFS) and overall survival (OS) in DLBCL [3], a significant proportion of patients are refractory or relapse following first-line treatment.

Enliven

Jürgen Jostontaining chemotherapy regimens represent the first-line treatment of choice, to be complemented with autologous transplantation in responding patients, if their clinical conditions are permissive, to consolidate remission, and to prolong survival. Nevertheless, many patients inadequately respond to